ARCHIVES

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

This article is from The Cancer Letter archive.

Vol. 39 No. 39 | October 18, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

May 28, 1999

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976